FINWIRES · TerminalLIVE
FINWIRES

CapitaLand Ascendas REIT Reallocates SG$30.9 Million to Debt Repayment

By

CapitaLand Ascendas REIT (SGX:A17U) plans to reallocate SG$30.9 million from its SG$903.5 million fund raise towards debt repayment rather than for part-financing a potential acquisition, according to a filing to the Singapore stock exchange on Thursday.

The company had initially earmarked S$30.4 million to partially finance the potential acquisition of a light industrial asset in Singapore; however, it has since dropped the plan and plans to use the funds for debt repayment purposes.

Out of the total gross proceeds, SG$4.2 million was used to pay the estimated fees and expenses incurred in connection with the equity fund raising, while the reallocated SG$30.9 million was fully deployed for debt repayment purposes, bringing the cumulative utilization across these two categories to SG$35.1 million.

The total gross proceeds of SG$903.5 million were raised through a multi-tranche equity fund raising earlier this year, which included a private placement of 249.4 million units at SG$2.406 per unit alongside a concurrent preferential offering.

Related Articles

Asia

Kim Forest Enterprise Wins NT$110 Million Genome Sequencing Kit Supply Deal

Kim Forest Enterprise (TPE:6645) won a tender to supply whole genome sequencing assay kits to a national hospital in Taiwan under a contract worth NT$110 million, according to a Wednesday Taiwan Exchange filing.Shares slid about 2% in Thursday's late morning trade.The contract runs from June 10, 2026, to Dec. 31, 2028.Kim Forest said the deal is expected to expand its business operations and boost revenue.

$TPE:6645
Asia

Beijing Balance Medical Tech to Buy Back Up to 100 Million Yuan Worth of Shares

Beijing Balance Medical Technology (SHA:688198) plans to repurchase shares worth between 50 million yuan and 100 million yuan, according to a Shanghai bourse filing on Thursday.The company will buy back between 359,583 shares and 719,165 shares, which represents 0.26% to 0.52% of the company's total shares, within 12 months after the approval of the board of directors.The maximum repurchase price will be 139.05 yuan per share.The repurchased shares will be used for the company's employee stock ownership plan or equity incentives.The medical device manufacturer's shares rose 1% during the morning trade.

$SHA:688198
Asia

MediaTek's Sales Edge Up in April; Shares Drop 3%

MediaTek (TPE:2454) booked consolidated net sales of NT$47.4 billion in May, up 1.5% from NT$46.7 billion in April, according to a Wednesday Taiwan Exchange filing.Shares slid about 3% in Thursday's late morning trade.MediaTek did not provide further details in the filing.

$TPE:2454